Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 049307/0013 | |
| Pages: | 3 |
| | Recorded: | 05/29/2019 | | |
Attorney Dkt #: | 2014-1119 |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
2
|
|
Patent #:
|
|
Issue Dt:
|
10/21/2014
|
Application #:
|
13876265
|
Filing Dt:
|
03/27/2013
|
Publication #:
|
|
Pub Dt:
|
08/01/2013
| | | | |
Title:
|
ANTI-HUMAN CCR7 ANTIBODY, HYBRIDOMA, NUCLEIC ACID, VECTOR, CELL, PHARMACEUTICAL COMPOSITION, AND ANTIBODY-IMMOBILIZED CARRIER
|
|
|
Patent #:
|
|
Issue Dt:
|
11/29/2016
|
Application #:
|
14489898
|
Filing Dt:
|
09/18/2014
|
Publication #:
|
|
Pub Dt:
|
01/08/2015
| | | | |
Title:
|
ANTI-HUMAN CCR7 ANTIBODY, HYBRIDOMA, NUCLEIC ACID, VECTOR, CELL, PHARMACEUTICAL COMPOSITION, AND ANTIBODY-IMMOBILIZED CARRIER
|
|
Assignee
|
|
|
12-2, KITA 21-JOU NISHI, KITA-KU, SAPPORO-SHI |
HOKKAIDO, JAPAN 011-0021 |
|
Correspondence name and address
|
|
WENDEROTH, LIND & PONACK, LLP.
|
|
1025 CONNECTICUT AVENUE, N.W.
|
|
SUITE 500
|
|
WASHINGTON, DC 20036
|
Search Results as of:
05/11/2024 09:55 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|